Advanced Gastric and Gastro-esophageal Junction Adenocarcinoma
1 clinical trials · Condition
◉ Watch Advanced Gastric and Gastro-esophageal Junction Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Sintilimab and Nab-paclitaxel in Second-line Treatment of Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma (NCT04140318) | Chinese Academy of Medical Sciences | 2019-11-15 |
Track Advanced Gastric and Gastro-esophageal Junction Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.